Literature DB >> 20824441

Patient registries: utility, validity and inference.

Rachel Richesson1, Kendra Vehik.   

Abstract

Patient registries are essential tools for public health surveillance and research inquiry, and are a particularly important resource for understanding rare diseases. Registries provide consistent data for defined populations and can support the study of the distribution and determinants of various diseases. One advantage of registries is the ability to observe caseload and population characteristics over time, which might facilitate the evaluation of disease incidence, disease etiology, planning, operation and evaluation of services, evaluation of treatment patterns, and diagnostic classification. Any registry program must collect high quality data to be useful for its stated purpose. Registries can be developed for many different needs, and caution should be taken in interpreting registry data, which has inherent biases. We describe the methodological issues, limitations, and ideal features of registries to support various rare disease purposes. The future impact of registries on our understanding and interventions for rare diseases will depend upon technological and political solutions for global cooperation to achieve consistent data (via standards) and regulations for various registry applications.

Entities:  

Mesh:

Year:  2010        PMID: 20824441     DOI: 10.1007/978-90-481-9485-8_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

1.  The Rare Diseases Clinical Research Network Contact Registry update: features and functionality.

Authors:  Rachel L Richesson; Rebecca Sutphen; Denise Shereff; Jeffrey P Krischer
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

Review 2.  Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders.

Authors:  Carla E M Hollak; Johannes M F G Aerts; Ségolène Aymé; Jeremy Manuel
Journal:  Orphanet J Rare Dis       Date:  2011-04-16       Impact factor: 4.123

3.  Considerations Before Establishing an Environmental Health Registry.

Authors:  Vinicius C Antao; Oleg I Muravov; James Sapp; Theodore C Larson; L Laszlo Pallos; Marchelle E Sanchez; G David Williamson; D Kevin Horton
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

4.  Clinical research informatics and electronic health record data.

Authors:  R L Richesson; M M Horvath; S A Rusincovitch
Journal:  Yearb Med Inform       Date:  2014-08-15

Review 5.  Dementia registries around the globe and their applications: A systematic review.

Authors:  Karolina Krysinska; Perminder S Sachdev; John Breitner; Miia Kivipelto; Walter Kukull; Henry Brodaty
Journal:  Alzheimers Dement       Date:  2017-05-30       Impact factor: 21.566

6.  Arizona Alzheimer's Registry: Strategy and Outcomes of a Statewide Research Recruitment Registry.

Authors:  K T Saunders; J B Langbaum; C J Holt; W Chen; N High; C Langlois; M Sabbagh; P N Tariot
Journal:  J Prev Alzheimers Dis       Date:  2014-09

Review 7.  The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance.

Authors:  A Cassio; C Corbetta; I Antonozzi; F Calaciura; U Caruso; G Cesaretti; R Gastaldi; E Medda; F Mosca; E Pasquini; M C Salerno; V Stoppioni; M Tonacchera; G Weber; A Olivieri
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

8.  Advancing the microbiome research community.

Authors:  Curtis Huttenhower; Rob Knight; C Titus Brown; J Gregory Caporaso; Jose C Clemente; Dirk Gevers; Eric A Franzosa; Scott T Kelley; Dan Knights; Ruth E Ley; Anup Mahurkar; Jacques Ravel; Owen White
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

9.  Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases.

Authors:  Caron Molster; Leanne Youngs; Emma Hammond; Hugh Dawkins
Journal:  Orphanet J Rare Dis       Date:  2012-08-10       Impact factor: 4.123

10.  Standardization of Questions in Rare Disease Registries: The PRISM Library Project.

Authors:  Rachel Lynn Richesson; Denise Shereff; James Everett Andrews
Journal:  Interact J Med Res       Date:  2012-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.